dacarbazine has been researched along with Hematologic Malignancies in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beilken, A; Corbacioglu, S; Dilloo, D; Driever, PH; Dürken, M; Gielen, GH; Hoffmann, M; Karremann, M; Krämer, N; Kramm, CM; Kulozik, A; Scheurlen, W; von Bueren, AO; Wiese, M | 1 |
| Miyakita, Y; Momota, H; Narita, Y; Shibui, S | 1 |
| Arigita, M; Balasch, J; Castelo-Branco, C; Durán, M; Nomdedeu, B; Rabanal, A | 1 |
| Casasnovas, O; Coiffier, B | 1 |
| Bauer, K; Engert, A; Hübel, K; Monsef, I; Rancea, M; Skoetz, N | 1 |
| Ogawa, M | 1 |
| Tear, S | 1 |
| Andrieu, JM; Berthou, C; Casassus, P; Colonna, P; Delwail, V; Desablens, B; Gastinne, T; Jais, JP; Moles, MP; Sénécal, D | 1 |
| Dugan, M; Gerson, SL; Izbicka, E; Raymond, E; Soda, H; Von Hoff, DD | 1 |
| Bonmassar, E; d'Amati, G; Graziani, G; Leonetti, C; Portarena, I; Scarsella, M; Tentori, L; Zupi, G | 1 |
2 review(s) available for dacarbazine and Hematologic Malignancies
| Article | Year |
|---|---|
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophosphamide; Dacarbazine; Disseminated Intravascular Coagulation; Doxorubicin; Etoposide; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Prednisone; Procarbazine; Purpura, Thrombocytopenic, Idiopathic; Randomized Controlled Trials as Topic; Receptors, Thrombopoietin; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Viral Vaccines | 2012 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Hematologic Neoplasms; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 2003 |
1 trial(s) available for dacarbazine and Hematologic Malignancies
| Article | Year |
|---|---|
Secondary hematological malignancies associated with temozolomide in patients with glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Female; Follow-Up Studies; Glioma; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prognosis; Retrospective Studies; Temozolomide; Young Adult | 2013 |
7 other study(ies) available for dacarbazine and Hematologic Malignancies
| Article | Year |
|---|---|
Haematological malignancies following temozolomide treatment for paediatric high-grade glioma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Austria; Child; Child, Preschool; Dacarbazine; Female; Follow-Up Studies; Germany; Glioma; Hematologic Neoplasms; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Switzerland; Temozolomide | 2017 |
Unintended pregnancy after gonadal failure chemoprevention with gonadotropin-releasing hormone agonist in women with hematologic malignancies.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Hematologic Neoplasms; Humans; Infant, Newborn; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy, Unplanned; Primary Ovarian Insufficiency; Time Factors; Triptorelin Pamoate; Vinblastine; Young Adult | 2009 |
Hematological cancer: Localized non-bulky Hodgkin lymphoma--future questions.
Topics: Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Hematologic Neoplasms; Hodgkin Disease; Humans; Radiotherapy; Survival Analysis; Treatment Outcome; United States; Vinblastine | 2012 |
American Society of Hematology--48th Annual Meeting and Exposition. Therapeutic approaches for hematological cancers. 9-12 December 2006 Orlando, FL, USA.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Clinical Trials, Phase I as Topic; Dacarbazine; Hematologic Neoplasms; Hematology; Humans; Hydrazines; Leukemia, Myeloid; Multiple Myeloma; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-kit; Sulfonamides; Temozolomide | 2007 |
Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hematologic Neoplasms; Hodgkin Disease; Humans; Lung Neoplasms; Male; Multicenter Studies as Topic; Neoplasm Staging; Prospective Studies; Radiation Dosage; Radiotherapy; Randomized Controlled Trials as Topic; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; Vinblastine | 2008 |
Activity of temozolomide against human tumor colony-forming units.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Cell Division; Dacarbazine; Digestive System Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Hematologic Neoplasms; Humans; Lung Neoplasms; Neoplasm Proteins; Neoplastic Stem Cells; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urogenital Neoplasms | 1997 |
Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Dacarbazine; Drug Evaluation, Preclinical; Hematologic Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Survival Analysis; Survival Rate; Temozolomide | 2002 |